Sign In
Buy OXM
$38.14
+0.260 (+0.686%)
At Close: Jun 23, 2026
Regeneron aims to make 300K doses of covid antibody drug this fall
03:18pm, Thursday, 08'th Oct 2020
HHS chief Alex Azar said Thursday the US may have hundreds of thousands of doses of Regeneron's antibody drug this fall. The firm has 50K doses now, and aims for 300k in a few months.
Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs
02:30pm, Thursday, 08'th Oct 2020
-- Lilly submitted request for emergency use authorization (EUA) for monotherapy to U.S. Food and Drug Administration (FDA) -- New data show combination...
Eli Lilly in deal to supply COVID-19 drugs to low-income countries | MarketScreener
11:10am, Thursday, 08'th Oct 2020Eli Lilly to work with Bill & Melinda Gates Foundatin to get COVID antibody therapy to poorer countries
11:00am, Thursday, 08'th Oct 2020
Eli Lilly and Co. undefined said Thursday it has entered an agreement with the Bill & Melinda Gates Foundation to ensure access to Lilly's COVID-19 antibody...
Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
10:45am, Thursday, 08'th Oct 2020
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire via COMTEX/ --
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda...
Lilly seeks emergency authorization for Covid antibody drug - Times of India
05:05am, Thursday, 08'th Oct 2020
Antibodies from Lilly and Regeneron Pharmaceuticals Inc. could provide a powerful addition to the handful of treatments doctors are now using to treat
Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints
02:51am, Thursday, 08'th Oct 2020Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints
02:51am, Thursday, 08'th Oct 2020Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints
02:51am, Thursday, 08'th Oct 2020This is the best news about a coronavirus cure we’ve gotten in weeks
02:15am, Thursday, 08'th Oct 2020
A company announced clinical trial results for a new type of medicine developed specifically to treat the novel coronavirus. Eli Lilly says the data it has on hand proves that its monoclonal antibo…
Antibody drugs are no cure but seem promising for COVID-19
12:00am, Thursday, 08'th Oct 2020
WASHINGTON - They’re not cures and it’s not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental an...
Trump admits that a vaccine won't be available until after election
10:56pm, Wednesday, 07'th Oct 2020
Trump has admitted that a vaccine will likely not be available until after the November 3 election and falsely calls the antibody cocktail drug he received as treatment for the coronavirus a 'cure'.
Eli Lilly Asks FDA to Authorize Covid-19 Antibody Drug--2nd Update | MarketScreener
08:34pm, Wednesday, 07'th Oct 2020Type-2 Diabetes Market 2020 High Demands, Trends Analysis, Size, Share, Growth Strategies, Geographical Analysis and Forecast Till 2025
08:17pm, Wednesday, 07'th Oct 2020
Oct 07, 2020 (Market Insight Reports) --
Selbyville, Delaware Market Study Report, LLC, has recently added a report on the Type-2 Diabetes market which...
